Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: Two pilot studies in animal bony defect model

被引:34
作者
Yun, Pil-Young [1 ]
Kim, Young-Kyun [1 ,4 ,5 ]
Jeong, Kyung-In [1 ]
Park, Ju-Cheol [2 ,4 ,5 ]
Choi, Yeon-Jo [3 ]
机构
[1] Seoul Natl Univ, Sect Dent, Dept Oral & Maxillofacial Surg, Bundang Hosp, Songnam, South Korea
[2] Seoul Natl Univ, Sch Dent, Dept Oral Histol, Seoul, South Korea
[3] Korea Univ, Med Ctr, Dept Dent, Div Prosthodont, Seoul, South Korea
[4] Seoul Natl Univ, Sch Dent, Dept Dent, Seoul, South Korea
[5] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea
关键词
Biphasic calcium phosphate; Bone morphogenetic protein; Hydroxyapatite; Beta-tricalcium phosphate; Collagen; RAT CALVARIAL DEFECTS; TRICALCIUM PHOSPHATE; SPINE ARTHRODESIS; RHBMP-2; CARRIERS; REGENERATION; CERAMICS; MACROPOROSITY; SYSTEM; MATRIX; BLOCK;
D O I
10.1016/j.jcms.2014.07.011
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: The purpose of these two pilot studies using animal bony defect models was to evaluate the influence of bone morphogenetic protein (BMP) and proportion of hydroxyapatite (HA)/beta-tricalcium phosphate (beta-TCP) in biphasic calcium phosphate (BCP) graft on new bone formation. Methods: In this study, four kinds of synthetic osteoconductive bone materials known for bone growth scaffold, OSTEON (TM) II(HA:beta-TCP 30:70), OSTEON (TM) III (HA:beta-TCP 20:80), OSTEON (TM) II Collagen, and OSTEON (TM) III Collagen, were prepared as BCP graft materials. In pilot study 1, three BCP materials (OSTEON (TM) II, OSTEON (TM) III, and OSTEON (TM) II Collagen) were grafted in rabbit calvarial defects after impregnating in rhBMP-2. OSTEON (TM) II without the rhBMP-2 impregnation was included in the study as the control. The amount of new bone was examined and measured histologically at 2, 4, and 8 weeks. In pilot study 2, four BCP materials (OSTEON (TM) II, OSTEON (TM) III, OSTEON (TM) II Collagen, and OSTEON (TM) III Collagen) were grafted in beagle dog mandibular defects after soaking in the rhBMP-2. The amount of total bone and new bone were measured three-dimensionally using microCT and healing process was examined histologically at 2, 4, and 8 weeks. Results: In pilot study 1, rhBMP-2 impregnated groups showed more new bone formation than the rhBMP-2 free group. In pilot study 2, increased new bone formation was observed in time-dependent manner after graft of BCP and BCP-collagen (OSTEON (TM) II, OSTEON (TM) III, OSTEON (TM) II Collagen, and OSTEON (TM) III Collagen) impregnated with rhBMP-2. Also, BCP with a higher proportion of HA (30% HA) showed more favorable result in new bone formation and space maintenance, especially at the 8 weeks. Conclusion: From the results of the pilot studies, rhBMP-2 played positive roles in new bone formation and BCP could become a scaffold candidate for rhBMP-2 impregnation to induce new bone formation. Moreover, BCP with a higher proportion of HA (30% HA) could be considered more appropriate for rhBMP-2 carrier. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1909 / 1917
页数:9
相关论文
共 37 条
[21]   Effects of Polycaprolactone-Tricalcium Phosphate, Recombinant Human Bone Morphogenetic Protein-2 and Dog Mesenchymal Stem Cells on Bone Formation: Pilot Study in Dogs [J].
Kim, Sun-Jong ;
Kim, Myung-Rae ;
Oh, Jin-Sub ;
Han, Inho ;
Shin, Sang-Wan .
YONSEI MEDICAL JOURNAL, 2009, 50 (06) :825-831
[22]   Histologic and clinical evaluation for maxillary sinus augmentation using macroporous biphasic calcium phosphate in human [J].
Lee, Ji Hyun ;
Jung, Ui Won ;
Kim, Chang Sung ;
Choi, Seong Ho ;
Cho, Kyoo Sung .
CLINICAL ORAL IMPLANTS RESEARCH, 2008, 19 (08) :767-771
[23]   The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli [J].
Lee, Ji-Hyun ;
Kim, Chang-Sung ;
Choi, Kyung-Hee ;
Jung, Ui-Won ;
Yun, Jeong-Ho ;
Choi, Seong-Ho ;
Cho, Kyoo-Sung .
BIOMATERIALS, 2010, 31 (13) :3512-3519
[24]   Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model [J].
Louis-Ugbo, J ;
Kim, HS ;
Boden, SD ;
Mayr, MT ;
Li, RC ;
Seeherman, H ;
D'Augusta, D ;
Blake, C ;
Jiao, AP ;
Peckham, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (05) :1050-1059
[25]   Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons [J].
Miranda, DAO ;
Blumenthal, NM ;
Sorensen, RG ;
Wozney, JM ;
Wikesjö, UME .
JOURNAL OF PERIODONTOLOGY, 2005, 76 (02) :210-220
[26]   Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites [J].
Noshi, T ;
Yoshikawa, T ;
Dohi, Y ;
Ikeuchi, M ;
Horiuchi, K ;
Ichijima, K ;
Sugimura, M ;
Yonemasu, K ;
Ohgushi, H .
ARTIFICIAL ORGANS, 2001, 25 (03) :201-208
[27]  
Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
[28]   Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration [J].
Sigurdsson, TJ ;
Fu, E ;
Tatakis, DN ;
Rohrer, MD ;
Wikesjo, UME .
CLINICAL ORAL IMPLANTS RESEARCH, 1997, 8 (05) :367-374
[29]   Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model:: a dose-response study [J].
Tatakis, DN ;
Koh, A ;
Jin, L ;
Wozney, JM ;
Rohrer, MD ;
Wikesjö, UME .
JOURNAL OF PERIODONTAL RESEARCH, 2002, 37 (02) :93-100
[30]  
Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO